News
Theorem Clinical Research to Present Webinar on Best Practices for Conducting Early-Phase Oncology Trials
(King of Prussia, PA; August 21, 2014) – Theorem Clinical Research, a leading contract research organization (CRO) that optimizes trial conduct, will present the webinar, “Adaptive Design in Early-Phase Oncology Trials — Best Practices for Conduct,” at 10 a.m. EST on Nov. 12.
Theorem experts Connie Wierman, MBA, vice president of biopharmaceutical development; Jeff Joseph, senior director of statistics; and Scott Currence, director, service partnerships, will team up with Howard Grossberg, M.D., president of Grossberg Pharmaceutical Consulting and senior oncology medical advisor to Theorem, to discuss best practices for implementing adaptive design for early-phase oncology trials for sites, CROs and sponsors.
“We’re offering a look at the efficiencies of adaptive trial design for early-phase oncology studies,” said John Potthoff, Theorem president and CEO. “Attendees will learn how Theorem’s therapeutic expertise and specialty in analytic-based development have led to more effective trial modifications at interim stages by using accumulated information as trials progress.”
Key takeaways of this informational webinar include:
• Standard approaches to optimizing the management of adaptive trial design.
• Best practices to support sites during such study conduct.
• Integration and review of data for patient safety and trial objectives.
Anyone involved in clinical development — especially in early-phase oncology studies —and operational staff responsible for monitoring oncology sites are encouraged to attend this free webinar. Additional information and registration information are now available at www.appliedclinicaltrialsonline.com/conduct.
About Theorem Clinical Research
Theorem Clinical Research Inc. is a leading midsized provider of comprehensive clinical research and development services with offices in more than 30 countries and a customer base comprised of some of the world’s top pharmaceutical, biotech and medical device companies. As a forerunner in medical device and drug-device combination trials with notable capabilities in pharmaceuticals and biologics, Theorem offers deep expertise in a broad range of therapeutic areas and in all phases of development. With some of the industry’s top scientists and most advanced clinical analytics capabilities, Theorem ensures smooth-running, successful trials. For the full-service, right-size global research partner, don’t think twice. THINK THEOREM.
###